I noticed you mentioned SNTS growth at 35-40%. Not sure if you ever noticed or commented, but I posted about a stem cell company on the ACRX board ... I feel best in breed as they have revenue/products approved and being sold. They have had over 35% growth the past two quarters and projecting at least that going forward with margins above 70%. Very tightly held and owned by big Swiss investors ... very low float and O/S. Trading very tightly between $10-$11 for awhile now and expecting news. Just thought I'd point you that way if you're interested! I've owned it since about $6.
I'm sorry...I guess that always helps. I don't usually like low float/volume stocks, but OSIR is different. Let me know what you think ... It is unique and some of the "drive bys" don't like it ...like the Street's "Adam Fartstein" , but they don't get the soon to be released KABOOM associated with Grafix and Ovation sales!!!